Search research articles
Contact Us
Filters
Showing results (51-60 of 120) with videos related to
Page
of 12
Sort By:
Psychiatry Research
|
July 1, 2024
Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol
Beverly Jieu, Eliska B Sykorova, Cathrin Rohleder, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 2, 2009
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
Dagmar Koethe, Andrea Giuffrida, Daniela Schreiber, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 3, 2004
Antibodies to infectious agents in individuals with recent onset schizophrenia
F Markus Leweke, Christoph W Gerth, Dagmar Koethe, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 3, 2014
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse
Daniela Muhl, Markus Kathmann, Carolin Hoyer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 16, 2011
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Journal of Proteomics
|
March 3, 2012
Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry
Julian A J Jaros, Paul C Guest, Hassan Ramoune, et al.
Journal of Proteomics
|
May 30, 2012
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Proteomics
|
April 16, 2013
Application of meta-analysis methods for identifying proteomic expression level differences
Bob Amess, Wolfgang Kluge, Emanuel Schwarz, et al.
Frontiers in Psychiatry
|
December 11, 2020
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
Timo Woelfl, Cathrin Rohleder, Juliane K Mueller, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 30, 2019
Cannabis use and psychosis: a review of reviews
Alkomiet Hasan, Rupert von Keller, Chris Maria Friemel, et al.
Page
of 12
Search research articles
Search
Showing results (51-60 of 120) with videos related to
Sort By:
Page
of 12
Psychiatry Research
|
July 1, 2024
Alterations to sphingolipid metabolism from antipsychotic administration in healthy volunteers are restored following the use of cannabidiol
Beverly Jieu, Eliska B Sykorova, Cathrin Rohleder, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 2, 2009
Anandamide elevation in cerebrospinal fluid in initial prodromal states of psychosis
Dagmar Koethe, Andrea Giuffrida, Daniela Schreiber, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
March 3, 2004
Antibodies to infectious agents in individuals with recent onset schizophrenia
F Markus Leweke, Christoph W Gerth, Dagmar Koethe, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
May 3, 2014
Increased CB2 mRNA and anandamide in human blood after cessation of cannabis abuse
Daniela Muhl, Markus Kathmann, Carolin Hoyer, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
December 16, 2011
Differential phosphorylation of serum proteins reflecting inflammatory changes in schizophrenia patients
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Journal of Proteomics
|
March 3, 2012
Clinical use of phosphorylated proteins in blood serum analysed by immobilised metal ion affinity chromatography and mass spectrometry
Julian A J Jaros, Paul C Guest, Hassan Ramoune, et al.
Journal of Proteomics
|
May 30, 2012
Protein phosphorylation patterns in serum from schizophrenia patients and healthy controls
Julian A J Jaros, Daniel Martins-de-Souza, Hassan Rahmoune, et al.
Proteomics
|
April 16, 2013
Application of meta-analysis methods for identifying proteomic expression level differences
Bob Amess, Wolfgang Kluge, Emanuel Schwarz, et al.
Frontiers in Psychiatry
|
December 11, 2020
Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Emotion, Cognition, and Attention: A Double-Blind, Placebo-Controlled, Randomized Experimental Trial in Healthy Volunteers
Timo Woelfl, Cathrin Rohleder, Juliane K Mueller, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
September 30, 2019
Cannabis use and psychosis: a review of reviews
Alkomiet Hasan, Rupert von Keller, Chris Maria Friemel, et al.
Page
of 12